Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial

• Published in: Current controlled trials in cardiovascular medicine Vol. 22; no. 1; p. 785
• Main Authors: Smyth, Penelope, Watson, Kaitlyn E, Tsuyuki, Ross T
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 08.11.2021; BioMed Central; BMC
• Subjects: Ambulatory care; Anxiety; Care and treatment; Chronic illnesses; Clinical outcomes; Complications and side effects; Cost control; Counseling; Depression; Depression, Mental; Diagnosis; Disease; Healthcare delivery; Medical referrals; Mental depression; Multiple sclerosis; Nurse practitioner; Nurse practitioners; Nurses; Patient satisfaction; Physicians; Primary care; Psychiatrists; Psychological aspects; Psychologists; Quality of life; Risk factors; Services; Study Protocol; Systematic review; Young adults; Canada
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-021-05726-3

Abstract Background Canada has one of the highest rates of multiple sclerosis (MS) in the world. Treatments and supports for people with MS (PwMS) have become increasingly complex, requiring individualized and adaptive care. Specialized NPs provide advanced skills to those with complex medical conditions, with potential to enhance the health, functioning, and quality of life for PwMS. This study aims to determine the effect of a Nurse Practitioner (NP) on depression and anxiety levels in PwMS. Methods We will perform a parallel randomized controlled trial. PwMS who are followed by general private-practice neurologists will be randomly assigned to the intervention group (NP-led care) or the ‘usual care’ control group (general neurologist or family physician and registered nurse support). In the intervention group, the NP will assess and provide care to the MS patient and their caregiver at a baseline visit, with 3-month and 6-month follow-up visits. PwMS in the control group will receive usual care provided by their community neurologists or family physicians with the standard assistance provided by registered nurses experienced in MS care. The primary outcome will be the difference in change in the patient’s anxiety and depression scores as measured by the validated Hospital Anxiety and Depression Scale (HADS) questionnaire at 3 months. Secondary outcomes will include difference in change in HADS at 6 months; Modified Fatigue Impact Scale scores (MSIF) at 3 and 6 months; EQ-5D scores at 3 and 6 months; caregiver health-related quality of life in MS measures (CAREQOL-MS) at 3 and 6 months; number of visits and phone calls to healthcare professionals recorded by patient, and satisfaction with NP-led care vs usual care measured by the validated Consultant Satisfaction Questionnaire. Discussion Findings from this study will contribute to exploring benefits of advanced nursing practitioner interventions for PwMS followed by general neurologists and family physicians in a community setting. It will provide evidence of the benefits of NP-led care for PwMS and offer an alternative healthcare resource for management of MS. Trial registration ClinicalTrials.gov Pro00069595. Retrospectively registered on June 26, 2020. Protocol version: January 2017, version 1.